Literature DB >> 619841

Prognosis in schizophrenia. Prognostic predictors and outcome.

R C Bland, J H Parker, H Orn.   

Abstract

Eighty-eight of 92 first-admission schizophrenics from 1963, an incidence by first admission cohort, were followed up in 1974 and 1975. Epidemiologically the sample was more comparable to lower European rates and expectancy rather than to higher American figures. Prior to follow-up, factors said to predict outcome were scored. This prognostic information was complete for 79 cases. Outcome was measured on a variety of criteria. The patients fell into a "poor prognosis" group based on the prognostic indicators, which were of little value in predicting prognosis within this group. However, patients who received extensive service during the follow-up period had poorer outcomes. Outcome was better than in most earlier studies of schizophrenia, but similar to that in some other recent studies of first-admission patients; also, the use of phenothiazines, short-term hospitalization, and community services may play a part. The failure of prognostic indicators to predict more than about 25% of the outcome variance for this group of "poor prognosis" patients supports the viewpoint that "good" and "poor" prognosis schizophrenia are two different entities.

Entities:  

Mesh:

Year:  1978        PMID: 619841     DOI: 10.1001/archpsyc.1978.01770250074007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  9 in total

1.  When and how does schizophrenia produce social deficits?

Authors:  H Häfner; B Nowotny; W Löffler; W an der Heiden; K Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

2.  Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?

Authors:  Martin Harrow; Thomas H Jobe
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

3.  A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Authors:  Martin Harrow; Thomas H Jobe; Robert N Faull; Jie Yang
Journal:  Psychiatry Res       Date:  2017-06-22       Impact factor: 3.222

4.  Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.

Authors:  A Pietzcker; A Poppenberg; J Schley; B Müller-Oerlinghausen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

5.  [Marked life events prior to an acute schizophrenic episode. Comparison of a sample of first admissions with a normal sample (author's transl)].

Authors:  M Malzacher; J Merz; D Ebnöther
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

6.  Social disability in schizophrenia: the controlled prospective Burghölzli study II. Premorbid living situation and social adjustment--comparison with a normal control sample.

Authors:  R Isele; J Merz; M Malzacher; J Angst
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 7.  Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.

Authors:  Kumar B Saha; Li Bo; Sai Zhao; Jun Xia; Stephanie Sampson; Rashid U Zaman
Journal:  Cochrane Database Syst Rev       Date:  2016-04-05

8.  [The Strauss-Carpenter Scale: evaluation of its prognostic value for the 5-year outcome of schizophrenic patients].

Authors:  H J Möller; W Scharl; D von Zerssen
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

Review 9.  Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis.

Authors:  Johanna Immonen; Erika Jääskeläinen; Hanna Korpela; Jouko Miettunen
Journal:  Early Interv Psychiatry       Date:  2017-04-27       Impact factor: 2.732

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.